These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 35433143)
81. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center. Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983 [TBL] [Abstract][Full Text] [Related]
82. Mechanical circulatory support for refractory cardiogenic shock in Takotsubo syndrome: a case report and review of the literature. Aalberts JJJ; Klinkenberg TJ; Mariani MA; van der Harst P Eur Heart J Case Rep; 2017 Aug; 1(1):ytx005. PubMed ID: 31020064 [TBL] [Abstract][Full Text] [Related]
83. Successful Management of Hemodynamically Unstable Takotsubo Cardiomyopathy With Milrinone. Pahuja KH; Wasef N; Hasan S; Fatima T; Hamilton S; Seelagy M Cureus; 2022 Aug; 14(8):e27820. PubMed ID: 36106204 [TBL] [Abstract][Full Text] [Related]
84. Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials. Kuno T; Takagi H; Ando T; Kodaira M; Numasawa Y; Fox J; Bangalore S Catheter Cardiovasc Interv; 2021 Apr; 97(5):E636-E645. PubMed ID: 32894797 [TBL] [Abstract][Full Text] [Related]
85. Cardiogenic shock induced by Takotsubo cardiomyopathy: A new therapeutic option. Silva MP; Vilela EM; Lopes RL; de Morais GP; Fernandes P; Santos L; Dias A; Ribeiro VG Rev Port Cardiol; 2015 Nov; 34(11):695.e1-4. PubMed ID: 26497606 [TBL] [Abstract][Full Text] [Related]
86. Acquired left ventricular outflow tract obstruction and cardiogenic shock treated with beta-blockers. Taylor JS; Purnell R; Yousef ZR Am J Emerg Med; 2009 Mar; 27(3):373.e1-373.e3. PubMed ID: 19328398 [TBL] [Abstract][Full Text] [Related]
87. A case of Takotsubo cardiomyopathy with cardiogenic shock after influenza infection successfully recovered by IMPELLA support. Nakamura M; Nakagaito M; Hori M; Ueno H; Kinugawa K J Artif Organs; 2019 Dec; 22(4):330-333. PubMed ID: 31228028 [TBL] [Abstract][Full Text] [Related]
88. Multiple Unfavorable Echocardiographic Findings in Takotsubo Cardiomyopathy Are Associated with Increased In-Hospital Events and Mortality. Kagiyama N; Okura H; Matsue Y; Tamada T; Imai K; Yamada R; Kume T; Hayashida A; Neishi Y; Yoshida K J Am Soc Echocardiogr; 2016 Dec; 29(12):1179-1187. PubMed ID: 27742241 [TBL] [Abstract][Full Text] [Related]
89. Long term survival after early unloading with Impella CP Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984 [TBL] [Abstract][Full Text] [Related]
90. Fulminant lymphocytic myocarditis: Prediction of successful weaning from Impella support for cardiogenic shock. Saegusa H; Komatsu J; Sugane H; Hosoda H; Imai RI; Nakaoka Y; Nishida K; Seki SI; Kubokawa SI; Kawai K; Hamashige N; Doi Y J Cardiol Cases; 2022 Mar; 25(3):159-162. PubMed ID: 35261701 [TBL] [Abstract][Full Text] [Related]
91. Recurrent Takotsubo Cardiomyopathy in a Patient With Hypertrophic Cardiomyopathy Leading to Cardiogenic Shock Requiring VA-ECMO. Husaini M; Baker JN; Cresci S; Bach R; LaRue SJ JACC Case Rep; 2020 Jun; 2(7):1014-1018. PubMed ID: 34317404 [TBL] [Abstract][Full Text] [Related]
92. The Impella CP device for acute mechanical circulatory support in refractory cardiac arrest. Vase H; Christensen S; Christiansen A; Therkelsen CJ; Christiansen EH; Eiskjær H; Poulsen SH Resuscitation; 2017 Mar; 112():70-74. PubMed ID: 27751862 [TBL] [Abstract][Full Text] [Related]
93. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock. Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047 [TBL] [Abstract][Full Text] [Related]
94. Management of spontaneous coronary artery dissection complicated by cardiogenic shock using mechanical circulatory support with the Impella device. Sharma S; Polak S; George Z; LeDoux J; Sohn R; Stys A; Jeon C; Ghazzawi Y; Wood M Catheter Cardiovasc Interv; 2021 Jan; 97(1):74-77. PubMed ID: 31876350 [TBL] [Abstract][Full Text] [Related]
95. Outcome of the impella device for acute mechanical circulatory support. Lemaire A; Anderson MB; Prendergast T; Stockmaster N; Goodman A; Lozane AM; Batsides G Innovations (Phila); 2013; 8(1):12-6. PubMed ID: 23571788 [TBL] [Abstract][Full Text] [Related]
96. Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock. Madjarov JM; Katz MG; Madzharov S; Fazal S; Robicsek F J Cardiothorac Surg; 2021 May; 16(1):132. PubMed ID: 34001192 [TBL] [Abstract][Full Text] [Related]
97. Management of Takotsubo Syndrome: A Comprehensive Review. Sattar Y; Siew KSW; Connerney M; Ullah W; Alraies MC Cureus; 2020 Jan; 12(1):e6556. PubMed ID: 32042529 [TBL] [Abstract][Full Text] [Related]
98. Reverse takotsubo cardiomyopathy followed by left ventricle outflow tract obstruction: A dangerous relay race. Mele M; Pepe M; Maggi A; Troccoli R; Rutigliano D; Villella A J Cardiol Cases; 2019 Aug; 20(2):61-64. PubMed ID: 31440314 [TBL] [Abstract][Full Text] [Related]
99. Outcomes of Renal Function in Cardiogenic Shock Patients With or Without Mechanical Circulatory Support. Upadhyaya VD; Alshami A; Patel I; Douedi S; Quinlan A; Thomas T; Prentice J; Calderon D; Asif A; Sen S; Mehra A; Hossain MA J Clin Med Res; 2021 May; 13(5):283-292. PubMed ID: 34104280 [TBL] [Abstract][Full Text] [Related]